AUGUST 30, 2004
VOLUME 1 NO. 15
 

Clinical
Silent MIs go undetected if pain doesn't sound the alarm

I'll take the combo: Triple therapy adds up to one great result in knocking out aggressive prostate cancers.

Not all shook up: Quetiapine promises relief from Alzheimer's agitation, minus the stroke-risk side effect.

Those bleedin' headaches: Neurology study shows frovatriptan can fend off menstrual migraines.

In breast cancer Tx, go by the book or watch deaths soar

Creaming the competition: Tacrolimus outperforms pimecrolimus for treating
atopic dermatitis.

Boning up on new drugs: Why you're more likely to hear from patients hungry for the latest osteo meds.

Tumours byte: Computer-aided screening ups breast cancer detection, slashes false negatives.

Boosting confidence: UK meningitis vaccine push a raging success, but babes may need a top up, says Lancet study.

Monday, bloody Monday: Another reason to hate the start of the week: it's stroke's
fave time to strike.

Government and Medicine
Tried, tested, and true?: Health Canada's adverse drug reaction tracking system goes under the microscope.

Features
Spin the medicine wheel: Wearing many hats, Dr Gilles Pinette mixes aboriginal and coventional medicine. Take your pick: publisher/writer/TV personality/GP.

Deliver me: ...from late nights and lawsuits. For Canadian FPs, delivering babies is a fraught business.

The doors of infection: Brass doorknobs found to be more MRSA-resistant than superbug-friendly stainless steel.

Hitting snooze: Morning-phobic teens have a new excuse for sleeping in: "It's my circadian rhythm, Mum!"

A time to heal: Specialists push to eradicate undertreated pain, but hit an anti-opiate brick wall.

In their stride: Masai Barefoot Technology shoes make big claims but can they walk the walk?

United front: Six centres across Canada form the new disease-busting Public Health Agency.

UBC cashes in on endowment fund: Scooge mentality sent packing by provincial pot of gold.

Conflict of interest declarations: on the eve of extinction?

What's the buzz?: West Nile Virus has certainly generated lots of ink, but does it live up to the hype?

"Don't let it define you": Dr Jacques Voyer takes his psych duties BEYOND ON-CALL.

Sweet coffin nails: Tobacco giant tests flavoured ciggies in Quebec. Are we candy-coating cancer sticks? 25

Deadly appetite: Prader-Willi kids suffer from fatal insatiability; new UBC research may spell relief.

Tanning cancer's hide?: Derms speak out against claims that shade-hounds are magnets for internal cancers.

Back to school special section
Trouble with the three Rs: WHAT TO TELL YOUR PATIENTS helps you brush up on learning difficulties.

Back-to-script season: A tag team approach to treating ADHD in kids after their summer drug holiday.

"Exercise? Yuck!": Docs and schools join forces to curb Saskatchewan kids' expanding girth.

Departments
Across Canada: News highlights from coast to coast to coast.

NEW COLUMN
Personal Finance: Your money and your life: How to avoid decisions that are hazardous to your wealth
.

News in Brief: Bite-size treats from the international world of medicine

Classics: Reviews of films, CDs that deserve a second look.

Editorial: Do we take you where you want to go?

Letters: All about Omalizumab ...

Practice Management
Mind your manners: Being naughty or nice can determine if patients stay or go.

Give yourself a break: Medicine's not the bowl of cherries it once was. That doesn't mean you can't have fun.

  back to top of page

 

 

 

 

 

 

 

 

 
© Parkhurst Publishing Privacy Statement
Legal Terms of Use